Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/12 → 6/1/18 |
Funding
- Parexel (Prot# TH-CR-406/SARC021 // Prot# TH-CR-406/SARC021)
- Threshold Pharmaceuticals, Inc. (Prot# TH-CR-406/SARC021 // Prot# TH-CR-406/SARC021)
Prot# TH-CR-406/SARC021: A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
- Agulnik, Mark (PD/PI)
Project: Research project